WO2012168275A3 - Sunscreens comprising uv absorbers of benzotriazol structure - Google Patents

Sunscreens comprising uv absorbers of benzotriazol structure Download PDF

Info

Publication number
WO2012168275A3
WO2012168275A3 PCT/EP2012/060655 EP2012060655W WO2012168275A3 WO 2012168275 A3 WO2012168275 A3 WO 2012168275A3 EP 2012060655 W EP2012060655 W EP 2012060655W WO 2012168275 A3 WO2012168275 A3 WO 2012168275A3
Authority
WO
WIPO (PCT)
Prior art keywords
sunscreens
absorbers
derivative
benzotriazol
benzotriazol structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2012/060655
Other languages
French (fr)
Other versions
WO2012168275A2 (en
Inventor
Christine Mendrok-Edinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Priority to US14/124,898 priority Critical patent/US20140219938A1/en
Priority to EP12726422.4A priority patent/EP2720672A2/en
Priority to BR112013031538A priority patent/BR112013031538A2/en
Publication of WO2012168275A2 publication Critical patent/WO2012168275A2/en
Publication of WO2012168275A3 publication Critical patent/WO2012168275A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/415—Aminophenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a composition for topical application in the form of an oil-in-water (O/W) emulsion comprising in a physiologically acceptable medium at least a dibenzoylmethane derivative, an amino substituted hydroxybenzophenone derivative and a benzotriazol derivative.
PCT/EP2012/060655 2011-06-08 2012-06-06 Sunscreens Ceased WO2012168275A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/124,898 US20140219938A1 (en) 2011-06-08 2012-06-06 Sunscreens
EP12726422.4A EP2720672A2 (en) 2011-06-08 2012-06-06 Sunscreens comprising uv absorbers of benzotriazol structure
BR112013031538A BR112013031538A2 (en) 2011-06-08 2012-06-06 sunscreens

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11169195.2 2011-06-08
EP11169195 2011-06-08
EP11173599.9 2011-07-12
EP11173599 2011-07-12

Publications (2)

Publication Number Publication Date
WO2012168275A2 WO2012168275A2 (en) 2012-12-13
WO2012168275A3 true WO2012168275A3 (en) 2013-09-26

Family

ID=46229485

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/060655 Ceased WO2012168275A2 (en) 2011-06-08 2012-06-06 Sunscreens

Country Status (4)

Country Link
US (1) US20140219938A1 (en)
EP (1) EP2720672A2 (en)
BR (1) BR112013031538A2 (en)
WO (1) WO2012168275A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3010209T3 (en) * 2014-07-25 2025-04-01 Basf Se Sunscreen formulations optimized for the formation of vitamin d

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006114381A1 (en) * 2005-04-28 2006-11-02 Ciba Specialty Chemicals Holding Inc. Use of benzotriazole derivatives for photostabilisation
WO2009027258A2 (en) * 2007-08-24 2009-03-05 Basf Se Mixtures comprising benzotriazoles and merocyanines
EP2078521A1 (en) * 2008-01-08 2009-07-15 Stada Arzneimittel Ag Cosmetic composition containing a derivative of benzotriazol and an AHR antagonist
WO2011086124A1 (en) * 2010-01-15 2011-07-21 Dsm Ip Assets B.V. 2 - phenyl - 1, 2, 3 - benzotriazoles for uv radiation absorbance
WO2012168286A2 (en) * 2011-06-08 2012-12-13 Dsm Ip Assets B.V. Topical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104800098A (en) * 2007-07-09 2015-07-29 巴斯夫欧洲公司 Water based concentrated product forms of oil-soluble organic uv absorbers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006114381A1 (en) * 2005-04-28 2006-11-02 Ciba Specialty Chemicals Holding Inc. Use of benzotriazole derivatives for photostabilisation
WO2009027258A2 (en) * 2007-08-24 2009-03-05 Basf Se Mixtures comprising benzotriazoles and merocyanines
EP2078521A1 (en) * 2008-01-08 2009-07-15 Stada Arzneimittel Ag Cosmetic composition containing a derivative of benzotriazol and an AHR antagonist
WO2011086124A1 (en) * 2010-01-15 2011-07-21 Dsm Ip Assets B.V. 2 - phenyl - 1, 2, 3 - benzotriazoles for uv radiation absorbance
WO2012168286A2 (en) * 2011-06-08 2012-12-13 Dsm Ip Assets B.V. Topical composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAROLINA GOMES BENEVENUTO ET AL: "Influence of the Photostabilizer in the Photoprotective Effects of a Formulation Containing UV-Filters and Vitamin A", PHOTOCHEMISTRY AND PHOTOBIOLOGY, vol. 86, no. 6, 29 September 2010 (2010-09-29), pages 1390 - 1396, XP055073264, ISSN: 0031-8655, DOI: 10.1111/j.1751-1097.2010.00806.x *

Also Published As

Publication number Publication date
WO2012168275A2 (en) 2012-12-13
EP2720672A2 (en) 2014-04-23
US20140219938A1 (en) 2014-08-07
BR112013031538A2 (en) 2017-03-21

Similar Documents

Publication Publication Date Title
WO2009004629A3 (en) A method for decreasing symptoms of alcohol consumption
WO2013177594A3 (en) Xylitol-based anti-mucosal compositions and related methods and compositions
WO2009129246A3 (en) Compositions and methods for preparing and using same
HK1198358A1 (en) Sustained release composition of prostacyclin
WO2009089494A3 (en) Pharmaceutical compositions
WO2010069532A8 (en) Antibodies against human angiopoietin 2
WO2009051460A3 (en) Peptide coupled ascorbic acid derivatives
WO2009155513A3 (en) Immunoglobulins with reduced aggregation
WO2010037059A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
WO2013034855A3 (en) Combination of carrageenan and c-glycoside and uses thereof
WO2008087348A3 (en) Emulsion comprising at least one retinoid and benzoyl peroxide
WO2009012871A3 (en) Uv filter capsule
WO2012095752A3 (en) Personal care compositions
WO2010004197A3 (en) Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
WO2011014025A3 (en) Derivative of hydroxy-cinnamic acid in which a peptide has been bonded, production method for same, and cosmetic composition comprising same
WO2010017368A3 (en) Methods and compositions for treating anxiety
WO2010046061A3 (en) Cosmetic and/or pharmaceutical formulations
WO2010005565A3 (en) Method of treating glycogen storage disease
WO2009112590A3 (en) Substances raising the activation threshold of immune cell
WO2009115084A3 (en) Pyrrolopyrimidine derivatives, and use thereof
WO2007144521A3 (en) Cosmetic composition for topical use comprising wasabi
WO2010012386A3 (en) Method for treating hypersensitive teeth
WO2014043230A3 (en) Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof
WO2012168286A3 (en) Sunscreens with reduced cloth staining tendency
WO2012168282A3 (en) Sunscreens with reduced whitening effect

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12726422

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2012726422

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12726422

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14124898

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013031538

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013031538

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20131206